UK Innovation & Science Seed Fund News

30th March 2020, London: The UK Innovation and Science Seed Fund (UKI2S) has published an independent economic analysis showing how its investment and continuing support have generated benefits for early stage companies and for the UK economy as a whole. The report, by economic research specialists SQW Consulting, demonstrates the unique value of UKI2S in […]

read more

11 March 2020: GyreOx Therapeutics (GyreOx), developing its novel MACRO platform, has launched today with backing from UKI2S and LifeArc. Developing complex molecules able to target intracellular interactions, the company will develop therapy for cancer and autoimmune diseases based on research carried out by Professor James Naismith (University of Oxford, previously at the University of St […]

read more

Founded by UK Innovation & Science Seed Fund (UKI2S) with co-investment from LifeArc & Parkwalk to advance a diabetic macular edema gene therapy and other pipeline products Cambridge, February 5 2020: Ikarovec, which is developing novel gene therapies to treat major ophthalmic indications, has launched today with £2.5m of seed funding from leading UK start-up investors […]

read more

1 2 3 31